2025 annual financial data
Barinthus Biotherapeutics 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -54,194,349 USD and net income was -66,583,233 USD.
Operating cash flow was -47,979,000 USD.
Get free Barinthus Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -54,194,349 USD
- Net income
- -66,583,233 USD
- Operating cash flow
- -47,979,000 USD